Corporate calendar for Indaptus Therapeutics, Inc. (INDP): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-0.05 | $8M |
| 2026-09-14 | ||
| 2026-09-14 | $0.06 | $3M |
| 2026-09-14 | $36.39 | $67M |
| 2026-09-14 | $-0.03 | $278M |
| 2026-09-14 | $898M |
Price
| Price | $3.21 |
| Market Cap | $364M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Related companies: ATXI · AZTR · GTBP · LIPO · NKGN · PBM · PTIX
Explore sector: Healthcare · Biotechnology
More sections of INDP: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks